Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
publishing date : 2021 - 10 - 15 tags : Positive save search
Genmab Announces that Janssen has Received Positive CHMP Opinion for RYBREVANT® (amivantamab) for Patients with Advanced Non-small Cell Lung Cancer with EGFR Exon 20 Insertion Mutations, After Failure of Platinum-based Therapy
Published: 2021-10-15 (Crawled : 18:00) - globenewswire.com
GNMSF | $281.02 3.83% 210
|
Health Technology
|
| O: 0.53%
H: 0.91%
C: 0.91%
JNJ | News | $145.74 0.67% 0.0% 9.3M
|
Health Technology
|
| O: 0.58%
H: 0.0%
C: 0.0%
GMAB | $28.32 -0.74% -0.74% 240K
|
Health Technology
|
| O: 0.41%
H: 1.23%
C: 1.07%
lung cancer positive therapy cancer chmp
Positive Covid-19 Test
Published: 2021-10-15 (Crawled : 17:00) - taylordevices.com
TAYD | $46.55 -2.43% -2.49% 26K
|
Producer Manufacturing
|
| O: 1.3%
H: 0.34%
C: 0.34%
covid test positive covid-19
Merck Receives Positive CHMP Opinion for VAXNEUVANCE™ (Pneumococcal 15-valent Conjugate Vaccine) in Individuals 18 Years of Age and Older
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
MRK | $125.23 -0.11% 0.0% 6M
|
Health Technology
|
| O: -0.17%
H: 1.1%
C: 0.17%
positive chmp vaccine order pneumococcal
Bristol Myers Squibb Receives Positive CHMP Opinion for Zeposia (ozanimod) as a Treatment for Adult Patients with Moderately to Severely Active Ulcerative Colitis
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
BMY | $48.3 0.96% -0.1% 11M
|
Health Technology
|
| O: 0.71%
H: 1.0%
C: 0.43%
treatment positive chmp ulcerative colitis
Sacituzumab Govitecan Receives Positive CHMP Opinion as 2L Treatment for Adult Patients With Metastatic Triple-Negative Breast Cancer
Published: 2021-10-15 (Crawled : 14:00) - biospace.com/
GILD | $66.16 -1.15% -1.16% 6.4M
|
Health Technology
|
| O: 0.9%
H: 0.0%
C: 0.0%
treatment positive cancer chmp breast cancer als
AbbVie Receives CHMP Positive Opinion for Risankizumab (SKYRIZI®) for the Treatment of Adults with Active Psoriatic Arthritis in the European Union (EU)
Published: 2021-10-15 (Crawled : 13:15) - biospace.com/
ABBV | $164.66 0.25% -0.15% 4.5M
|
Health Technology
|
| O: 0.22%
H: 0.74%
C: 0.16%
treatment europe positive risankizumab chmp
Aspaveli® (pegcetacoplan) receives positive CHMP opinion for treatment of PNH
Published: 2021-10-15 (Crawled : 12:00) - prnewswire.com
APLS | $47.51 -1.08% -1.09% 1.9M
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: -2.48%
treatment positive chmp
Apellis and Sobi Receive Positive CHMP Opinion for Aspaveli® (pegcetacoplan) for the Treatment of PNH
Published: 2021-10-15 (Crawled : 12:00) - globenewswire.com
APLS | $47.51 -1.08% -1.09% 1.9M
|
Health Technology
|
| O: 0.25%
H: 0.0%
C: -2.48%
treatment positive chmp
Relief Reports U.S. Collaboration Partner Announces Journal of Infectious Diseases and Treatment Publishes Positive Aviptadil Data in High Comorbidity Critical COVID-19 Patients w/ Respiratory Failure
Published: 2021-10-15 (Crawled : 09:00) - biospace.com/
NRXP | News 0 d | $3.025 -27.63% -38.18% 760K
|
Manufacturing
|
| O: -6.63%
H: 2.97%
C: -7.73%
covid disease treatment aviptadil infectious disease positive collaboration respiratory
Gainers vs Losers
| 64% | 36% |
Top 10 Gainers
AGBA | $1.02 155.0% 57.94% 120M
|
Finance
ZCMD | $2.86 108.76% 52.1% 2.3M
|
Commercial Services
INVO | $1.555 104.6% 51.13% 5M
|
Health Technology
ISPC | $0.437 105.16% 49.53% 37M
|
Professional, Scientific, and T...
WLGS | $0.92 84.0% 45.65% 1.6M
|
OST | $0.499 21.38% 45.26% 1.9M
|
XPON | $3.1 60.62% 37.74% 17M
|
TIRX | $0.7 44.39% 30.74% 58M
|
BNTC | $6.92 44.17% 30.64% 3.5M
|
Health Technology
GGE | $0.035 19.86% 29.3% 64M
|
Your saved searches
Save your searches and get alerts when important news are released.